Our multivariate analysis and Random Forest modeling using the top 59 candidates predicted the combination of three biomarkers (SERPINA4, RBP4, and F12) best distinguish FP and SP ALS across time (Fig. 3). Here, RBP4 is linked to amyotrophic lateral sclerosis.